NCT07000500

Brief Summary

This study investigates the effect of nutritional supplementation on cognitive performance in older adults over a 90-day period using a double-blind randomized controlled design. The study includes 50 participants, aged 65 or older, randomly assigned to either a supplement group or a placebo group. Participants will be randomly assigned to either the experimental or control group. Assessments will be conducted pre- and post-intervention to determine the effect of the supplementation on cognitive performance. Key outcomes include cognitive status measured by MoCA, adherence to supplementation, and potential side effects. The findings will provide insights into the potential role of nutritional interventions in mitigating age-related cognitive decline.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 20, 2025

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

May 24, 2025

Completed
10 days until next milestone

First Posted

Study publicly available on registry

June 3, 2025

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 20, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 20, 2025

Completed
Last Updated

June 3, 2025

Status Verified

May 1, 2025

Enrollment Period

5 months

First QC Date

May 24, 2025

Last Update Submit

May 24, 2025

Conditions

Keywords

Cognitive DeclineMild Cognitive ImpairmentAgingNutritional Supplementation

Outcome Measures

Primary Outcomes (1)

  • Cognitive Performance

    Change in cognitive performance measured by MoCA before and after intervention (90 days)

    baseline and 90 days

Secondary Outcomes (5)

  • Adherence to supplementation protocol

    Daily, from Day 1 to Day 90

  • Occurrence of adverse effects

    Continuous, from baseline to Day 90

  • Self-reported use of other supplements

    Baseline and 90 days

  • Self-perceived quality of life

    baseline and 90 days

  • Depressive symptoms

    Baseline and Day 90

Study Arms (2)

Nutritional Supplement

EXPERIMENTAL

Participants in this arm will receive a daily dose of a nutritional supplement for 90 consecutive days. The supplement is administered orally and aims to improve cognitive performance in older adults with signs of cognitive decline. Participants will also complete cognitive assessments before and after the intervention.

Dietary Supplement: Nutritional Supplement

Placebo

PLACEBO COMPARATOR

Participants in this arm will receive a daily dose of an inert placebo that matches the supplement in appearance, taken orally for 90 consecutive days. The placebo is used as a control to compare the effects of the nutritional supplement on cognitive performance. Participants will undergo the same cognitive assessments as the experimental group.

Other: Placebo

Interventions

Nutritional SupplementDIETARY_SUPPLEMENT

Participants in this arm will receive a daily dose of a nutritional supplement for 90 consecutive days. The supplement is administered orally and aims to improve cognitive performance in older adults with signs of cognitive decline. Participants will also complete cognitive assessments before and after the intervention.

Nutritional Supplement
PlaceboOTHER

Participants in this arm will receive a daily dose of an inert placebo that matches the supplement in appearance, taken orally for 90 consecutive days. The placebo is used as a control to compare the effects of the nutritional supplement on cognitive performance. Participants will undergo the same cognitive assessments as the experimental group.

Placebo

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Community-dwelling adults aged 65 years or older Evidence of mild cognitive decline (score \< 26 on the Montreal Cognitive Assessment - MoCA) Ability to provide written informed consent Willingness and ability to comply with study procedures and attend scheduled evaluations

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Escola Superior de Saúde do Vale do Ave

Vila Nova de Famalicão, Braga District, 4760-409, Portugal

Location

MeSH Terms

Conditions

Cognitive Dysfunction

Interventions

Dietary Supplements

Condition Hierarchy (Ancestors)

Cognition DisordersNeurocognitive DisordersMental Disorders

Intervention Hierarchy (Ancestors)

FoodDiet, Food, and NutritionPhysiological PhenomenaFood and Beverages

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
PhD

Study Record Dates

First Submitted

May 24, 2025

First Posted

June 3, 2025

Study Start

April 20, 2025

Primary Completion

September 20, 2025

Study Completion

November 20, 2025

Last Updated

June 3, 2025

Record last verified: 2025-05

Locations